These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 38012318)
21. Human Monkeypox Experience in a Tertiary Level Hospital in Milan, Italy, between May and October 2022: Epidemiological Features and Clinical Characteristics. Candela C; Raccagni AR; Bruzzesi E; Bertoni C; Rizzo A; Gagliardi G; Canetti D; Gianotti N; Mileto D; Gismondo MR; Castagna A; Nozza S; Viruses; 2023 Mar; 15(3):. PubMed ID: 36992376 [TBL] [Abstract][Full Text] [Related]
22. Development of a novel serological assay for the detection of mpox infection in vaccinated populations. Yates JL; Hunt DT; Kulas KE; Chave KJ; Styer L; Chakravarthi ST; Cai GY; Bermúdez-González MC; Kleiner G; Altman D; Srivastava K; ; Simon V; Feihel D; McGowan J; Hogrefe W; Noone P; Egan C; Slifka MK; Lee WT J Med Virol; 2023 Oct; 95(10):e29134. PubMed ID: 37805977 [TBL] [Abstract][Full Text] [Related]
23. Primary Mpox and Secondary Syphilis in an HIV Patient: A Community Hospital Experience. Castanares GG; D'Assumpcao C; Fang M; McPheeters R; Heidari A J Investig Med High Impact Case Rep; 2023; 11():23247096231165739. PubMed ID: 37052123 [TBL] [Abstract][Full Text] [Related]
24. Successful Treatment of Recalcitrant Mpox Lesions With Intralesional Cidofovir in a Patient With HIV/AIDS. Buechler CR; Anderson ZJ; Kullberg SA; Miller DD; Ahiskali A; Schut R; Hylwa SA JAMA Dermatol; 2024 Feb; 160(2):235-236. PubMed ID: 38055229 [TBL] [Abstract][Full Text] [Related]
25. Clinical Features of Mpox Patients in Korea: A Multicenter Retrospective Study. Lim SY; Jo HJ; Lee SY; Ahn M; Kim Y; Jeon J; Kim ES; Chin B; Choi JP; Kim NJ J Korean Med Sci; 2024 Jan; 39(4):e19. PubMed ID: 38288533 [TBL] [Abstract][Full Text] [Related]
26. Monkeypox Outbreak in Peru. Ramírez-Soto MC Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374300 [TBL] [Abstract][Full Text] [Related]
27. Development of a partnership between academia, community, and government in response to the 2022 mpox outbreak in Japan. Kato M; Yoshimatsu F; Yamamoto T; Kobayashi N; Kikuchi T; Matsuoka S; Matano T; Iwahashi K; Ikushima Y; Shiono S; Ishikane M; Morioka S; Nakamoto T; Yoshimi I; Saito T Nihon Koshu Eisei Zasshi; 2024 Feb; 71(2):103-107. PubMed ID: 37821379 [TBL] [Abstract][Full Text] [Related]
28. Mpox: The Reemergence of an Old Disease and Inequities. Thornhill JP; Gandhi M; Orkin C Annu Rev Med; 2024 Jan; 75():159-175. PubMed ID: 37788486 [TBL] [Abstract][Full Text] [Related]
29. A global update of mpox (monkeypox) in children. Sam-Agudu NA; Martyn-Dickens C; Ewa AU Curr Opin Pediatr; 2023 Apr; 35(2):193-200. PubMed ID: 36809304 [TBL] [Abstract][Full Text] [Related]
30. Rapid and highly potent humoral responses to mpox nanovaccine candidates adjuvanted by thermostable scaffolds. Yan H; Peng Y; Zhang J; Peng R; Feng X; Su J; Yi H; Lu Y; Gao S; Liu J; Yang M; Liu X; Gao S; Chen Z Vaccine; 2024 Mar; 42(8):2072-2080. PubMed ID: 38423815 [TBL] [Abstract][Full Text] [Related]
31. Mpox in a Couple Living with HIV: Relapse or Reinfection? Rocha SQ; Fonsi M; Tancredi MV; Alencar HDR; Abbud A; da Silva MH AIDS Res Hum Retroviruses; 2023 Nov; 39(11):610-615. PubMed ID: 37140474 [TBL] [Abstract][Full Text] [Related]
32. Mpox in Nigeria: Perceptions and knowledge of the disease among critical stakeholders-Global public health consequences. Awoyomi OJ; Njoga EO; Jaja IF; Oyeleye FA; Awoyomi PO; Ibrahim MA; Saulawa MA; Galadima HB; Rowaiye AB; Olasoju TI; Idrisa JA; Olalere FDH; Olasoju MI; Adisa OH; Adetunji VE; Idemudia OO; Ezenduka EV; Oguttu JW PLoS One; 2023; 18(3):e0283571. PubMed ID: 36996122 [TBL] [Abstract][Full Text] [Related]
40. The Current State and Progress of Mpox Vaccine Research. Wang X; Gu Z; Sheng S; Song R; Jin R China CDC Wkly; 2024 Feb; 6(7):118-125. PubMed ID: 38405601 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]